Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.440
+0.010 (0.70%)
Feb 21, 2025, 4:00 PM EST - Market closed
SONN Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2018 |
| Revenue | 1 | 0.02 | 0.15 | 0.35 | 0.48 | - | Upgrade
|
| Revenue Growth (YoY) | 674.14% | -87.40% | -57.76% | -27.64% | - | - | Upgrade
|
| Cost of Revenue | 1.35 | 0.11 | 0.12 | 21.44 | 16.63 | 9.88 | Upgrade
|
| Gross Profit | -0.35 | -0.09 | 0.03 | -21.09 | -16.15 | -9.88 | Upgrade
|
| Selling, General & Admin | 7.44 | 6.13 | 7.13 | 8.58 | 8.94 | 7.53 | Upgrade
|
| Research & Development | 5.63 | 5.63 | 11.69 | - | - | - | Upgrade
|
| Operating Expenses | 13.07 | 11.76 | 18.82 | 8.58 | 8.94 | 7.53 | Upgrade
|
| Operating Income | -13.42 | -11.85 | -18.79 | -29.67 | -25.09 | -17.41 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.18 | 0.08 | -0.04 | -0.05 | -0.02 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.33 | 4.33 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -9.27 | -7.44 | -18.83 | -29.72 | -25.11 | -17.44 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.13 | - | Upgrade
|
| Pretax Income | -9.27 | -7.44 | -18.83 | -29.72 | -24.98 | -24.27 | Upgrade
|
| Net Income | -9.43 | -7.44 | -18.83 | -29.72 | -24.98 | -24.27 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 41.34 | Upgrade
|
| Net Income to Common | -9.43 | -7.44 | -18.83 | -29.72 | -24.98 | -65.6 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | - | - | Upgrade
|
| Shares Change (YoY) | 336.81% | 404.96% | 425.71% | - | - | - | Upgrade
|
| EPS (Basic) | -9.05 | -11.35 | -145.13 | -1204.14 | - | - | Upgrade
|
| EPS (Diluted) | -9.05 | -11.35 | -145.13 | -1204.14 | - | - | Upgrade
|
| Free Cash Flow | -8.43 | -8.61 | -21.34 | -27.77 | -22.56 | -15.69 | Upgrade
|
| Free Cash Flow Per Share | -8.08 | -13.14 | -164.47 | -1125.21 | - | - | Upgrade
|
| Gross Margin | -35.14% | - | 17.96% | - | - | - | Upgrade
|
| Operating Margin | -1342.00% | -63617.91% | -12714.47% | -8478.34% | -5187.36% | - | Upgrade
|
| Profit Margin | -942.94% | -39929.30% | -12741.58% | -8493.34% | -5165.97% | - | Upgrade
|
| Free Cash Flow Margin | -842.62% | -46213.48% | -14439.19% | -7936.59% | -4663.91% | - | Upgrade
|
| EBITDA | -13.41 | -11.84 | -18.78 | -29.66 | -25.07 | -17.4 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | -13.42 | -11.85 | -18.79 | -29.67 | -25.09 | -17.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.